Literature DB >> 11810003

Stroke in Saudi Arabia.

Saad Al Rajeh1, Adnan Awada.   

Abstract

In this review, the authors summarize 10 years of work on stroke in Saudi Arabia that has led to more than 25 publications. The incidence and prevalence of strokes were low when compared to those reported from Western countries, but this was mainly due to the younger age of the population. The overall distribution of stroke types was not different from that reported in other communities, with the exception of the low incidence of subarachnoid hemorrhage. However, the relatively high frequency of strokes in the young and strokes related to small artery disease, i.e. lacunar infarcts and cerebral hemorrhage, and the high prevalence of diabetes mellitus as a risk factor were quite distinctive. On the other hand, extracranial large artery disease was quite rare. Undetected and untreated hypertension and a low frequency of cigarette smoking in the stroke-prone age group could be one explanation of these findings. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 11810003     DOI: 10.1159/000047738

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  10 in total

1.  Ethnic variation in acute cerebrovascular disease: Analysis from the Qatar stroke registry.

Authors:  Naveed Akhtar; Abdul Salam; Saadat Kamran; Paula Bourke; Sujatha Joseph; Mark Santos; Rabia Khan; Furqan Irfan; Dirk Deleu; Rayaz A Malik; Ashfaq Shuaib
Journal:  Eur Stroke J       Date:  2016-08-10

2.  Level of awareness regarding stroke among Riyadh population.

Authors:  Mohammed K T Abutaima; Ammar Almaghrabi; Rashed Alhazzaa; Abdullah Alaydaa; Abdulhakim Alshuraymi; Meshari Alzahim; Sohaib Ashour; Mohammed Alayed; Mukhlid Alshamrani; Ammar Fathi M Khalifa
Journal:  J Family Med Prim Care       Date:  2021-01-30

3.  Epidemiology and etiology of young stroke.

Authors:  Dayna Griffiths; Jonathan Sturm
Journal:  Stroke Res Treat       Date:  2011-07-18

4.  Diabetic patients are at a higher risk of lacunar infarction and dyslipidemia: results of a comparative pilot study from King Fahad Hospital of the University, Saudi Arabia.

Authors:  Azra Zafar
Journal:  Neurosciences (Riyadh)       Date:  2017-01       Impact factor: 0.906

5.  Practice Patterns and Barriers for Intravenous Thrombolysis: A Survey of Neurologists in Saudi Arabia.

Authors:  Mohammed H Alanazy; Rima B Barakeh; Alanood Asiri; Maha F Edrees; Ahmad R Abuzinadah; Bandar N Aljafen; Taim Muayqil
Journal:  Neurol Res Int       Date:  2018-02-13

6.  Patterns and outcomes of stroke thrombolysis in a large tertiary care hospital in Riyadh, Saudi Arabia.

Authors:  Ismail A Khatri; Mohammed AlSkaini; AbdulRahman AlDayel; AlBoqami Qamra; Emad Masuadi; Mufadhi AlShammari; Athal AlKhalaf; Deema AlRasheed; Ali AlKhathaami; Nasir AlOtaibi; Maisoun Tarawneh; Khloud AlHizan
Journal:  Neurosciences (Riyadh)       Date:  2021-04       Impact factor: 0.906

7.  Time Window for Acute Stroke Treatment: Current Practice in King Abdullah Medical City Specialist Hospital in Makkah, Saudi Arabia.

Authors:  Amal Alkhotani; Yousef Alharbi; Hadeel Alghamdi; Hadeel Alshareef; Jannat A Abdulmuttalib; Amal Alsulami; Abdulaziz Alharbi
Journal:  Cureus       Date:  2022-09-07

Review 8.  Stroke in Saudi Arabia: a review of the recent literature.

Authors:  Asirvatham Alwin Robert; Marwan Mohamed Zamzami
Journal:  Pan Afr Med J       Date:  2014-01-15

9.  Molecular genetic studies in Saudi population; identified variants from GWAS and meta-analysis in stroke.

Authors:  Khalid Khalaf Alharbi; Imran Ali Khan; Mohammad Abdullah Alotaibi; Abdullah Saud Aloyaid; Haifa Abdulaziz Al-Basheer; Naelah Abdullah Alghamdi; Raid Saleem Al-Baradie; A M Al-Sulaiman
Journal:  Saudi J Biol Sci       Date:  2017-08-24       Impact factor: 4.219

Review 10.  Epidemiology, clinical and complications profile of diabetes in Saudi Arabia: a review.

Authors:  Tarik A Elhadd; Abdallah A Al-Amoudi; Ali S Alzahrani
Journal:  Ann Saudi Med       Date:  2007 Jul-Aug       Impact factor: 1.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.